The Controversy of Drug Hypersensitivity in Patients with Cystic Fibrosis and Review of the Literature

2021 ◽  
Author(s):  
Gokcen Dilsa Tugcu ◽  
Nagehan Emiralioglu ◽  
Ebru Yalcin ◽  
Umit Murat Sahiner ◽  
Deniz Dogru ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Drug Hypersensitivity ◽  
Review Of The Literature

Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature

Mycoses ◽  
2021 ◽  
Author(s):  
Mohanad Al‐Obaidi ◽  
Hamid Badali ◽  
Connie Cañete‐Gibas ◽  
Hoja P. Patterson ◽  
Nathan P. Wiederhold
Keyword(s):  
Cystic Fibrosis ◽  
Cystic Fibrosis Patient ◽  
Pulmonary Infection ◽  
Review Of The Literature

scholarly journals Once Daily Dosing of Aminoglycosides in Pediatric Cystic Fibrosis Patients: A Review of the Literature

2008 ◽  
Vol 13 (2) ◽  
pp. 68-75
Author(s):  
Sarah K. Wassil ◽  
Kristie M. Fox ◽  
James W. White
Keyword(s):  
Cystic Fibrosis ◽  
Review Of The Literature ◽  
Nursing Time ◽  
Once Daily ◽  
Development Of Resistance ◽  
Cystic Fibrosis Population ◽  
Antibiotic Effect ◽  
Home Administration ◽  
Post Antibiotic Effect

Patients with cystic fibrosis receive many courses of antibiotic therapy throughout their lifetime. Dosing aminoglycosides once daily has become common practice in many of these individuals. Due to ease of home administration, decreased nursing time, and improved quality of life, this regimen is being increasingly explored in the cystic fibrosis population. Because patients with cystic fibrosis have increased aminoglycoside clearance, once daily dosing may result in a prolonged time during the dosing interval when concentrations of the drug may be undetectable. This makes the use of once daily dosing of these antibiotics in patients with cystic fibrosis controversial. Although aminoglycosides exhibit a post antibiotic effect, the duration of this effect is unknown in humans; therefore, the development of resistance to the aminoglycoside is a concern. This manuscript will review the organisms most commonly associated with a pulmonary exacerbation of cystic fibrosis, the properties of the aminoglycoside that make once daily dosing feasible, the concept of once daily dosing in those with cystic fibrosis and the current literature regarding efficacy, monitoring, toxicity and concerns of resistance with once daily dosing in this population.

scholarly journals c.753_754delAG, a novel CFTR mutation found in a Chinese patient with cystic fibrosis: A case report and review of the literature

2019 ◽  
Vol 7 (15) ◽  
pp. 2110-2119
Author(s):  
Yu-Qing Wang ◽  
Chuang-Li Hao ◽  
Wu-Jun Jiang ◽  
Yan-Hong Lu ◽  
Hui-Quan Sun ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Case Report ◽  
Chinese Patient ◽  
Review Of The Literature

scholarly journals EPS4.9 Drug hypersensitivity in children with cystic fibrosis

2017 ◽  
Vol 16 ◽  
pp. S46 ◽  
Author(s):  
G.D. Tugcu ◽  
O. Uysal Soyer ◽  
S. Esref ◽  
M. Gharibzadeh Hizal ◽  
N. Emiralioglu ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Drug Hypersensitivity

Contraception in women with cystic fibrosis: a systematic review of the literature

Contraception ◽  
2016 ◽  
Vol 93 (1) ◽  
pp. 3-10 ◽  
Author(s):  
Andrea Hsu Roe ◽  
Sarah Traxler ◽  
Courtney A. Schreiber
Keyword(s):  
Systematic Review ◽  
Cystic Fibrosis ◽  
Review Of The Literature

The pathology of fibrosing colonopathy of cystic fibrosis: A study of 12 cases and review of the literature

1997 ◽  
Vol 28 (4) ◽  
pp. 395-399 ◽  
Author(s):  
Bruce R Pawel ◽  
Jean-Pierre de Chadarévian ◽  
Maria E Franco
Keyword(s):  
Cystic Fibrosis ◽  
Review Of The Literature ◽  
Fibrosing Colonopathy
Sign in / Sign up

Export Citation Format

Share Document